2,300 endangered species: Controversial de-extinction company Colossal Biosciences joins U.S. effort to preserve their DNA

Credit: Colossal Biosciences
Credit: Colossal Biosciences

The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on [June 25, 2026] to preserve cells, tissue and DNA from threatened and endangered species.

The company, Colossal Biosciences, said its goal was to store samples from every animal and plant protected under the Endangered Species Act, which includes more than 2,300 listings worldwide.

As more species face the risk of extinction, scientists see such biobanks as a critical backup. But concerns are also growing that the rise of genetic engineering and efforts to revive extinct species will erode support for on-the-ground conservation, which often requires protecting habitat from drilling, mining and other development.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

The announcement comes as the Trump administration has been rolling back protections on land and water, including through actions to weaken the Endangered Species Act, in favor of expanded oil and gas exploration, commercial fishing and other economic activities.

…

Under a memorandum of understanding, Colossal and the Fish and Wildlife Service will collaborate to identify high-priority actions, and the government will provide a list of which species it wants to prioritize.

This is an excerpt. Read the original post here



Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot-2026-10-11-at-10.24.21-AM
Viewpoint: RFK Jr.’s new CDC head Erica Schwartz greenlights hepatitis B vaccine study critics call “unethical and designed to cast doubts on its safety”
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot 2026-10-12 at 12.25
Tearful onions? CRISPR has a solution for that
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
Concerned-Farmer-at-Golden-Hour
GAHA: The corporate-created “healthier America” movement challenging what it claims is MAHA misinformation about modern farming, chemicals, and food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.